(TRUP) Trupanion - Overview

Sector: Financial Services | Industry: Insurance - Property & Casualty | Exchange: NASDAQ (USA) | Market Cap: 1.118m USD | Total Return: -25.9% in 12m

Pet Insurance, Subscriptions, Health Plans
Total Rating 29
Safety 36
Buy Signal 0.11
Insurance - Property & Casualty
Industry Rotation: -7.5
Market Cap: 1.12B
Avg Turnover: 9.49M USD
ATR: 4.59%
Peers RS (IBD): 2.4
Risk 5d forecast
Volatility56.7%
Rel. Tail Risk-11.2%
Reward TTM
Sharpe Ratio-0.57
Alpha-73.98
Character TTM
Beta1.512
Beta Downside2.231
Drawdowns 3y
Max DD56.53%
CAGR/Max DD-0.16
EPS (Earnings per Share) EPS (Earnings per Share) of TRUP over the last years for every Quarter: "2021-03": -0.31, "2021-06": -0.23, "2021-09": -0.17, "2021-12": -0.17, "2022-03": -0.22, "2022-06": -0.33, "2022-09": -0.32, "2022-12": -0.23, "2023-03": -0.6, "2023-06": -0.33, "2023-09": -0.1, "2023-12": -0.05, "2024-03": -0.16, "2024-06": -0.14, "2024-09": 0.03, "2024-12": 0.0391, "2025-03": 0.19, "2025-06": 0.22, "2025-09": 0.7669, "2025-12": 0.13, "2026-03": 0,
EPS CAGR: 22.61%
EPS Trend: 77.6%
Last SUE: -0.14
Qual. Beats: 0
Revenue Revenue of TRUP over the last years for every Quarter: 2021-03: 154.685, 2021-06: 168.26, 2021-09: 181.667, 2021-12: 194.379, 2022-03: 205.999, 2022-06: 219.411, 2022-09: 233.76, 2022-12: 246.009, 2023-03: 256.329, 2023-06: 270.566, 2023-09: 285.853, 2023-12: 295.857, 2024-03: 306.121, 2024-06: 314.8, 2024-09: 327.456, 2024-12: 337.307, 2025-03: 341.975, 2025-06: 353.557, 2025-09: 366.92, 2025-12: 376.853, 2026-03: null,
Rev. CAGR: 17.48%
Rev. Trend: 98.7%
Last SUE: 0.86
Qual. Beats: 16

Warnings

Choppy

Tailwinds

No distinct edge detected

Description: TRUP Trupanion

Trupanion, Inc. (TRUP) offers subscription-based medical insurance for cats and dogs. This business model provides recurring revenue, common in the insurance sector.

The company operates in the United States, Canada, Continental Europe, and Australia. It is segmented into Subscription Business and Other Business, serving pet owners and veterinarians.

Founded in 2000 as Vetinsurance International, Inc., the company rebranded to Trupanion, Inc. in 2013 and is headquartered in Seattle, Washington.

For a detailed financial breakdown of TRUP, consider exploring ValueRays comprehensive analysis.

Headlines to Watch Out For
  • Pet enrollment growth fuels subscription revenue
  • Veterinary partnership expansion drives new customer acquisition
  • Rising veterinary costs impact insurance claims
  • Regulatory changes could limit insurance product offerings
  • Interest rate hikes affect customer discretionary spending
Piotroski VR‑10 (Strict) 6.0
Net Income: 19.4m TTM > 0 and > 6% of Revenue
FCF/TA: 0.08 > 0.02 and ΔFCF/TA 3.46 > 1.0
NWC/Revenue: 2.10% < 20% (prev 19.27%; Δ -17.17% < -1%)
CFO/TA 0.10 > 3% & CFO 89.5m > Net Income 19.4m
Net Debt (-258.9m) to EBITDA (51.6m): -5.02 < 3
Current Ratio: 1.07 > 1.5 & < 3
Outstanding Shares: last quarter (43.6m) vs 12m ago 3.35% < -2%
Gross Margin: 19.46% > 18% (prev 0.14%; Δ 1.93k% > 0.5%)
Asset Turnover: 167.2% > 50% (prev 159.3%; Δ 7.83% > 0%)
Interest Coverage Ratio: 2.60 > 6 (EBITDA TTM 51.6m / Interest Expense TTM 13.8m)
Altman Z'' -0.64
A: 0.03 (Total Current Assets 440.0m - Total Current Liabilities 409.8m) / Total Assets 915.0m
B: -0.23 (Retained Earnings -206.5m / Total Assets 915.0m)
C: 0.04 (EBIT TTM 35.8m / Avg Total Assets 860.9m)
D: -0.38 (Book Value of Equity -204.4m / Total Liabilities 531.1m)
Altman-Z'' Score: -0.64 = B
Beneish M -2.08
DSRI: 0.98 (Receivables 301.9m/274.0m, Revenue 1.44b/1.29b)
GMI: 0.71 (GM 19.46% / 13.91%)
AQI: 3.04 (AQ_t 0.40 / AQ_t-1 0.13)
SGI: 1.12 (Revenue 1.44b / 1.29b)
TATA: -0.08 (NI 19.4m - CFO 89.5m) / TA 915.0m)
Beneish M-Score: -2.08 (Cap -4..+1) = BB
What is the price of TRUP shares? As of April 15, 2026, the stock is trading at USD 26.26 with a total of 364,813 shares traded.
Over the past week, the price has changed by +3.10%, over one month by +3.55%, over three months by -22.86% and over the past year by -25.92%.
Is TRUP a buy, sell or hold? Trupanion has received a consensus analysts rating of 4.17. Therefore, it is recommended to buy TRUP.
  • StrongBuy: 3
  • Buy: 1
  • Hold: 2
  • Sell: 0
  • StrongSell: 0
What are the forecasts/targets for the TRUP price?
Analysts Target Price 45.3 72.3%
Trupanion (TRUP) - Fundamental Data Overview as of 11 April 2026
P/E Trailing = 57.2
P/E Forward = 1428.5714
P/S = 0.7767
P/B = 2.9015
Revenue TTM = 1.44b USD
EBIT TTM = 35.8m USD
EBITDA TTM = 51.6m USD
Long Term Debt = 101.8m USD (from longTermDebt, last quarter)
Short Term Debt = 10.0m USD (from shortTermDebt, last quarter)
Debt = 111.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -258.9m USD (recalculated: Debt 111.8m - CCE 370.7m)
Enterprise Value = 858.9m USD (1.12b + Debt 111.8m - CCE 370.7m)
Interest Coverage Ratio = 2.60 (Ebit TTM 35.8m / Interest Expense TTM 13.8m)
EV/FCF = 11.40x (Enterprise Value 858.9m / FCF TTM 75.4m)
FCF Yield = 8.77% (FCF TTM 75.4m / Enterprise Value 858.9m)
FCF Margin = 5.24% (FCF TTM 75.4m / Revenue TTM 1.44b)
Net Margin = 1.35% (Net Income TTM 19.4m / Revenue TTM 1.44b)
Gross Margin = 19.46% ((Revenue TTM 1.44b - Cost of Revenue TTM 1.16b) / Revenue TTM)
Gross Margin QoQ = 30.26% (prev 16.37%)
Tobins Q-Ratio = 0.94 (Enterprise Value 858.9m / Total Assets 915.0m)
Interest Expense / Debt = 3.65% (Interest Expense 4.08m / Debt 111.8m)
Taxrate = 10.54% (663k / 6.29m)
NOPAT = 32.0m (EBIT 35.8m * (1 - 10.54%))
Current Ratio = 1.07 (Total Current Assets 440.0m / Total Current Liabilities 409.8m)
Debt / Equity = 0.29 (Debt 111.8m / totalStockholderEquity, last quarter 383.9m)
Debt / EBITDA = -5.02 (Net Debt -258.9m / EBITDA 51.6m)
Debt / FCF = -3.44 (Net Debt -258.9m / FCF TTM 75.4m)
Total Stockholder Equity = 360.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.26% (Net Income 19.4m / Total Assets 915.0m)
RoE = 5.39% (Net Income TTM 19.4m / Total Stockholder Equity 360.4m)
RoCE = 7.74% (EBIT 35.8m / Capital Employed (Equity 360.4m + L.T.Debt 101.8m))
RoIC = 6.69% (NOPAT 32.0m / Invested Capital 477.8m)
WACC = 10.57% (E(1.12b)/V(1.23b) * Re(11.30%) + D(111.8m)/V(1.23b) * Rd(3.65%) * (1-Tc(0.11)))
Discount Rate = 11.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.20%
[DCF] Terminal Value 73.67% ; FCFF base≈60.6m ; Y1≈74.8m ; Y5≈127.6m
[DCF] Fair Price = 38.81 (EV 1.43b - Net Debt -258.9m = Equity 1.69b / Shares 43.4m; r=10.57% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 77.60 | EPS CAGR: 22.61% | SUE: -0.14 | # QB: 0
Revenue Correlation: 98.69 | Revenue CAGR: 17.48% | SUE: 0.86 | # QB: 16
EPS next Quarter (2026-06-30): EPS=0.95 | Chg7d=+0.010 | Chg30d=+0.010 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-12-31): EPS=3.95 | Chg7d=+0.020 | Chg30d=+0.020 | Revisions Net=+1 | Growth EPS=+43.4% | Growth Revenue=+9.5%
EPS next Year (2027-12-31): EPS=4.25 | Chg7d=-0.110 | Chg30d=-0.110 | Revisions Net=-1 | Growth EPS=+7.6% | Growth Revenue=+8.8%
External Resources
Dataroma Stockcircle